Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin non mauris tincidunt, porttitor sapien et, fringilla ligula. Etiam vel ligula enim. Sed neque lorem, maximus et sapien vitae.
MAbSilico has just been attributed a grant of one million euros in the Bpifrance I-Nov competition. This rewards its software, which uses artificial intelligence and numeric simulation to guide therapeutic antibody discovery, reducing the risk of failure and the time during the development of these drug candidates before clinical tests. A revolution in the bio-drugs development process.